Triticum turanicum

Triticum turanicum (Khorasan Wheat): A Comprehensive Reference

1. Identity, Nomenclature, and Botanical Classification

Khorasan wheat or Oriental wheat (Triticum turgidum subsp. turanicum, also called Triticum turanicum) is a tetraploid wheat species. It is scientifically classified as Triticum turgidum subsp. turanicum (Jakubz.) Bowden, belonging to the Poaceae family and the Triticum genus within the Triticum turgidum complex of tetraploid wheats. It is a free-threshing wheat with an AABB genome constitution and a chromosome number of 2n = 4x = 28, distinguishing it from diploid and hexaploid wheat species.

Most of the known wheat species today are polyploid. Whereas common bread wheat is hexaploid, Khorasan wheat is tetraploid. The genome composition of T. aestivum is AABBDD (hexaploid), whereas that of the tetraploid T. durum is AABB. T. durum and other subspecies of T. turgidum share the same genomic composition, among which are T. turgidum ssp. polonicum and T. turgidum ssp. turanicum, also known respectively as Polish wheat and Khorasan wheat.

The taxonomic history of the species has been complex. The taxonomic classification of T. turgidum subsp. turanicum remained controversial for decades. Percival (1921) described it as T. orientale, referring to varieties from the Persian province of Khorasan, while Gökgöl (1961) proposed Anatolia as the primary center of origin. The most accredited current hypothesis is that T. turanicum originated as a natural hybrid between Polish wheat (T. polonicum) and cultivated emmer wheat (T. turgidum subsp. dicoccon), with possible involvement of durum wheat, a reconstruction confirmed by molecular analyses of Michalcová et al. (2014).

Other names for Khorasan include Oriental wheat and its botanical names, Triticum turgidum ssp. turanicum or Triticum turanicum. The grain is also known by colloquial names including Prophet's Wheat, King Tut's Wheat, and Camel's Tooth.

1.1 The KAMUT® Brand and Its Relation to the Species

The KAMUT® trademark indicates a specific and ancient variety of grain (Triticum turgidum ssp. turanicum, commonly Khorasan wheat), and guarantees certain attributes making studies sufficiently comparable. The trademark is held by Kamut International, Ltd. (Big Sandy, MT) and Kamut Enterprises of Europe (Oudenaarde, Belgium), and guarantees mainly a protein content of 12–18% and a selenium content between 400 and 1000 ppb, with quality specifications requiring that the grain must always be grown certified organic and never hybridized or genetically modified.

KAMUT® is not synonymous with Khorasan wheat, but rather a registered trademark that exclusively identifies the QK-77 cultivar, grown according to a specific specification. Kamut is a registered trademark used in marketing products of the protected cultivated turanicum variety QK-77, which was registered by the USDA in 1990, and today more than 2000 ha of Kamut brand grain are grown in a small region of North America centered between the borders of Montana, North Dakota, Alberta, and Saskatchewan.

1.2 Physical Characteristics

The grain is twice the size of modern-day wheat and has a rich, nutty flavor. The grains are twice the size of a modern wheat kernel, with a thousand-kernel weight of up to 60 grams. They contain more proteins, lipids, amino acids, vitamins, and minerals than modern wheat. The grain has an amber colour and a high vitreousness.

2. Origin, History, and Traditional Use

2.1 Geographic and Temporal Origins

Khorasan wheat derives its name from the historical province of Khorasan, a region in ancient Persia encompassing parts of modern-day northeastern Iran, southern Turkmenistan, northern Afghanistan, and Central Asia. This tetraploid grain is believed to have been domesticated around 10,000 years ago in the Fertile Crescent, the cradle of Neolithic farming that spans modern Iraq, Syria, Lebanon, Jordan, Israel, and southeastern Turkey.

The grain likely spread across Eurasia via trade routes such as the Silk Road, facilitating its integration into Persian and Central Asian farming practices from the Bronze Age onward. Khorasan or Oriental wheat (Triticum turanicum) is a neglected and underutilized tetraploid wheat species which probably survived over the centuries in subsistence farming systems in the Near East and Central Asia.

2.2 Traditional Cultivation and Culinary Use

Named after the Khorasan region of Northern Iran, Khorasan flour is produced from an ancient variety of durum wheat, Triticum turanicum. This wheat is likely descended from emmer and has been traditionally cultivated over the centuries in subsistence farming systems in the Near East and Central Asia. As a staple grain, it was consumed in its whole-kernel form, ground into flour for flatbreads and leavened breads, and used to prepare porridges and cooked grain dishes. It is an ancient species, native to eastern Persia, very close to durum wheat by morphological characteristics; due to higher plant height, low lodging tolerance, and high susceptibility against powdery mildew, Khorasan wheat is more suitable for organic farming systems.

2.3 Modern Rediscovery and Commercial History

In 1986, Robert "Bob" Quinn's company, Montana Flour & Grains, introduced the natural food industry to the ancient wheat called Khorasan, which was then marketed under the trademark KAMUT®, registered by Quinn's family in 1990. The variety was rediscovered in the 1970s by an American farmer who began cultivating it sustainably and organically, contributing to its growing popularity due to its superior nutritional qualities and distinctive flavor. A popular legend — which lacks firm historical verification — held that seeds were brought from an Egyptian tomb to Montana after World War II, giving rise to the popular name "King Tut's Wheat." Khorasan is the focus of much folklore and legend.

3. Key Constituents and Active Compounds

3.1 Macronutrient Profile

Khorasan wheat grains contain more proteins, lipids, amino acids, vitamins, and minerals than modern wheat. Nutritional analyses reveal higher protein levels in Khorasan accessions compared to modern cultivars, with some accessions reaching 13.85 g/100 g. The accessions also display distinctive sugar profiles, including elevated levels of raffinose, stachyose, fructose, and maltose. Both khorasan pasta and durum wheat pasta provide similar energy, fats, carbohydrates, and fibre, while protein content is higher in khorasan pasta.

Results of long-term compositional tracking revealed high variability in the amounts of macronutrients and nutraceuticals. In particular, from 1989 to 2012, there was a decreasing trend in starch content (ranging from 70.87 to 50.54/100 g) and amylose (from 41.48 to 31.46%).

3.2 Minerals

Mineral analysis of Khorasan accessions has indicated higher concentrations of potassium, phosphorus, magnesium, and manganese compared to modern cultivars. However, selenium content (2.4–4.5 μg/100 g in some studies) is low, likely reflecting limited soil availability in non-North American growing conditions.

Selenium content in KAMUT®-brand products grown in North America is substantially higher. It has been demonstrated that selenium content in KAMUT® khorasan bread was ten-fold higher than in modern durum bread. These high concentrations (up to ten times higher than common durum wheat) found in KAMUT® brand products are closely related to the geology of North American soils in Montana and Saskatchewan, which are naturally rich in this mineral. Selenium content in foods greatly depends on its concentration in the soil, and Se concentration in North American soil is reported to be higher than in Italy, which can in part explain the higher Se content of KAMUT® khorasan wheat, which is always cultivated in North America.

3.3 Antioxidant Phytochemicals

On the phytochemical side, Khorasan wheat is rich in carotenoids (especially lutein), polyphenols, ferulic acid, and tocols, with documented antioxidant activity. The content of polyphenols did not differ quantitatively between ancient and modern varieties, but results indicated that KAMUT® brand wheat contained one of the most diverse polyphenol profiles.

Whole grain Khorasan wheat provides antioxidant support both indirectly — by way of cofactors such as iron, zinc, copper, and selenium — and directly through antioxidant compounds such as ferulic acid, other polyphenols, carotenoids, and vitamin E, which are assumed to act in a synergistic manner.

In terms of the concentration of antioxidant compounds, selenium was almost 20 times higher in khorasan pasta than in durum wheat pasta, and total polyphenols were also higher in the former.

Oriental wheat (Triticum turgidum ssp. turanicum; Poaceae) is a tetraploid wheat species that has gained recognition as a superfood due to its high fiber content and nutrient density. Research published in 2025 also investigated the metabolite profiles and policosanol contents in the sprouts of Oriental wheat cultivars, employing ultra-high performance liquid chromatography–time-of-flight mass spectrometry (UHPLC-QTOF MS) methods to annotate compounds present across different cultivars.

3.4 Lipid Fraction

Khorasan wheat is higher in protein, minerals such as selenium, zinc, and magnesium, and certain fatty acids compared to modern wheat varieties. Research has examined whether the presence of polyphenols with estrogen-like activity (such as lignans) in khorasan products might influence fatty acid metabolism. It has been suggested that higher serum DHA observed in some khorasan wheat interventions could be due to a higher presence of compounds with estrogen-like activity such as polyphenols, as some papers report that cereal flavonoids and wheat aleurone polyphenols increase plasma EPA and DHA concentrations; however, final conclusions could not be drawn as specific classes of polyphenols were not individually evaluated in these studies.

4. Mechanisms of Action

4.1 Antioxidant Pathways

Selenium acts in the active site of several enzymes involved in cellular protection from oxidative damage, such as glutathione peroxidase and other selenoproteins. Selenium acts at the active site of key antioxidant enzymes — glutathione peroxidase and thioredoxin reductase — which are of importance for European populations that are often deficient.

Many studies have demonstrated that whole-grain cereal products have significant antioxidant potential, mainly related to their high vitamin E, carotenoid, and polyphenol (especially phenolic acids) content. The main approach used for investigating the mechanism of the protective effect of whole-grain cereal has been based on studying each compound separately. This approach ignores the synergy of action of the many compounds occurring in whole grains, which is poorly characterized, as well as the importance of the cereal matrix and its influence on the accessibility of compounds in the digestive tract and on their bioavailability.

4.2 Anti-Inflammatory Pathways

In vitro studies have shed light on specific signaling pathways. In Caco-2 and T84 cells, functional pasta extract made from ancient grains has been shown to downregulate protein expression of the pErk1/2 and NF-κB signaling pathways, thereby reducing inflammatory oxidative stress markers.

4.3 Gut Microbiota Modulation

Studies examining fecal metabolite profiling of rats fed experimental diets found some differences between durum wheat and khorasan pasta-fed rats, with a clear distinction between the groups strongly supported by the development of a very different microbiota in the two groups. This suggests that the unique phytochemical and fiber composition of T. turanicum may selectively modulate gut microbial communities, though this mechanism requires further investigation in human studies.

5. Scientific Evidence by Health Area

5.1 Cardiovascular Health

Evidence in Healthy Subjects

A replacement diet with organic khorasan wheat pasta and bread products was shown to exert a beneficial effect on cardiovascular risk factors (total cholesterol, LDL-cholesterol, blood glucose, total antioxidant capacity, and various pro-inflammatory cytokines) in a healthy population with no prior clinical manifestations of CVD. No such benefits were observed from a replacement diet using organic conventional Italian T. durum (pasta) and T. aestivum (bread) wheat. This was a randomized crossover trial published in the European Journal of Clinical Nutrition (Sofi et al., 2013).

Evidence in Patients with Acute Coronary Syndrome

A randomized double-blinded crossover trial examined whether a khorasan wheat replacement diet could provide additive protective effects in reducing lipid, oxidative, and inflammatory risk factors in patients with Acute Coronary Syndrome (ACS) compared to a modern wheat diet. The trial was conducted on 22 ACS patients (9 female; 13 male). Patients were assigned to consume products (bread, pasta, biscuits, and crackers) made either from organic semi-whole khorasan wheat or organic semi-whole control wheat for eight weeks. On average, patients ingested 62.0 g dry weight per day of khorasan or control semolina, and 140.5 g dry weight per day of khorasan or control flour. Consumption of khorasan wheat products resulted in significant amelioration in total cholesterol (−6.8%) and LDL-cholesterol. The consumption of Oriental wheat led to reduced serum cholesterol and glucose levels, along with lower ROS and lipid peroxidation, in patients with acute coronary syndrome.

Study limitations: The ACS trial enrolled only 22 patients. Funding from Kamut Enterprises of Europe is disclosed in this and related studies, representing a potential source of industry bias. All trials in this area used replacement diets (substituting all cereal products), not isolated supplements, making it impossible to attribute effects to any single constituent.

5.2 Type 2 Diabetes Mellitus

A randomized, double-blinded crossover trial was conducted with two intervention phases on 21 T2DM patients (14 females, 7 males). Participants were assigned to consume products (bread, pasta, crackers, and biscuits) made using semi-whole flour from either organic ancient khorasan wheat or modern control wheat for 8 weeks, in a random order, with an 8-week washout period between interventions.

The metabolic risk profile improved only after the khorasan intervention period, as measured by a reduction in total and LDL cholesterol (mean reduction: −3.7%). The study found that khorasan wheat produced significant improvements in total cholesterol, LDL cholesterol, glucose, and insulin in adults with T2DM. Subjects consuming a modern wheat diet experienced no significant effects on these same markers. Researchers also found patients consuming khorasan wheat presented a significant decrease in inflammatory markers, compared to a significant increase in inflammatory markers after the modern wheat intervention.

Despite the pleiotropic effects of medication, organic ancient khorasan consumption within an already beneficial Mediterranean diet provides additive protection in reducing hyperglycemia, ROS production, and inflammation in T2DM, which are key areas warranting control in secondary prevention.

The research was part-funded by a grant from Kamut Enterprises of Europe, a subsidiary of Kamut trademark holder Kamut International. This is an important consideration when evaluating the overall evidence base, as a substantial proportion of human clinical trials to date have received industry funding.

5.3 Irritable Bowel Syndrome (IBS)

A double-blinded randomised cross-over trial examined the effect of a replacement diet with organic, semi-whole-grain products derived from Triticum turgidum subsp. turanicum (ancient) wheat on IBS symptoms and inflammatory/biochemical parameters. The study used twenty participants (thirteen females and seven males, aged 18–59 years) classified as having moderate IBS. Participants received products (bread, pasta, biscuits, and crackers) made either from ancient or modern wheat for 6 weeks in a random order.

During the intervention period with ancient wheat products, patients experienced a significant decrease in the severity of IBS symptoms, such as abdominal pain (P < 0.0001), bloating (P = 0.004), satisfaction with stool consistency (P < 0.001), and tiredness (P < 0.0001). No significant difference was observed after the intervention period with modern wheat products. Similarly, patients reported significant amelioration in the severity of gastrointestinal symptoms only after the ancient wheat intervention period, as measured by the intensity of pain (P = 0.001), the frequency of pain (P < 0.0001), bloating (P < 0.0001), abdominal distension (P < 0.001), and quality of life (P < 0.0001).

The inflammatory profile showed a significant reduction in the circulating levels of pro-inflammatory cytokines, including IL-6, IL-17, interferon-γ, monocyte chemotactic protein-1, and vascular endothelial growth factor after the ancient wheat intervention period, but not after the control period. In conclusion, significant improvements in both IBS symptoms and the inflammatory profile were reported after the ingestion of ancient wheat products.

Evidence strength: This crossover trial enrolled only 20 participants, limiting the power and generalizability of its findings. As with the other human trials, the intervention used whole dietary replacement rather than an isolated supplement.

5.4 Antioxidant Status and Metabolic Risk in Healthy Volunteers

A study aimed to evaluate in healthy human subjects the antioxidative and diabetes-preventive properties of ancient KAMUT® khorasan wheat compared to modern wheat. The study was a randomized, non-blind, parallel arm study where the biochemical parameters of volunteers on a diet based on organic whole grain KAMUT® khorasan products were compared to a similar replacement diet based on organic whole grain modern durum wheat products. A total of 30 healthy volunteers were recruited and the intervention period lasted 16 weeks. Blood analyses were performed before and after the diet intervention.

Results indicated that compared to consumption of whole grain modern durum wheat bread, consumption of whole grain KAMUT® brand wheat bread resulted in more favorable outcomes based on measurement of antioxidant markers. This effect was correlated to the higher content of selenium and polyphenols in the KAMUT® brand wheat bread compared to the modern durum wheat bread.

5.5 Preclinical (Animal) Evidence

Research evaluated and compared the antioxidant effect of whole grain modern durum wheat bread and whole grain KAMUT® khorasan bread in rats, comparing baker's yeast and sourdough preparation methods. Total polyphenols and, in particular, selenium were significantly higher in the two KAMUT® brand wheat breads than in the whole grain durum wheat bread. Vitamin E and beta-carotene were in lower concentrations in baker's yeast khorasan bread compared to modern wheat bread, but both compounds were increased in the sourdough khorasan bread by the sourdough fermentation process.

After feeding these different breads to rats for seven weeks, the rats were then subjected to an exogenous oxidative stress. The rats fed the KAMUT® breads were better able to overcome the induced oxidative stress than those fed the modern durum bread.

Studies on rats also found clear distinctions between the fecal metabolite profiles of durum wheat and khorasan pasta-fed groups, strongly supported by the development of a very different microbiota in the two groups.

Animal and in vitro studies provide supporting mechanistic evidence but cannot be directly extrapolated to clinical outcomes in humans.

5.6 Non-Alcoholic Fatty Liver Disease (NAFLD)

A randomized clinical trial by Dinu et al. (published in the Journal of the American College of Nutrition, 2018) was identified in the literature as examining the effect of a Khorasan wheat-based replacement diet on the risk profile of patients with non-alcoholic fatty liver disease (NAFLD). This adds to the clinical breadth of research on the grain's potential metabolic applications, though the evidence base remains limited in sample size and research group diversity.

5.7 Evidence in Athletes

A pilot study by Dinu et al. (2019, published in PubMed, PMID 31347165) examined a khorasan wheat-based diet and its effects on the systemic inflammatory profile in semi-professional basketball players in a randomized crossover design. This study represents one of the few investigations of T. turanicum in an athletic population, though given its pilot status, conclusions remain preliminary.

6. Body Systems and Associated Health Areas

• Cardiovascular system: Khorasan wheat has been shown to reduce cardiovascular risk by lowering cholesterol and glucose levels, improving redox status, increasing serum potassium and magnesium, and reducing pro-inflammatory cytokine levels.
• Gastrointestinal system: Oriental wheat improved symptoms in irritable bowel syndrome (IBS) and suppressed associated inflammatory markers. Additional pilot research suggests effects on gut microbiota composition.
• Metabolic / endocrine system: Human clinical trials have recorded significant reductions in blood glucose and insulin in T2DM patients following khorasan wheat replacement diets.
• Oxidative stress / cellular protection: Selenium, present in elevated amounts in North American-grown khorasan wheat, acts in the active site of several enzymes involved in cellular protection from oxidative damage, such as glutathione peroxidase and other selenoproteins.
• Immune and inflammatory regulation: Reductions in multiple pro-inflammatory cytokines (IL-6, IL-17, IFN-γ, MCP-1, VEGF) have been observed in human clinical trials in IBS patients consuming T. turanicum products.
• Hepatic system: A randomized clinical trial has examined potential benefits in NAFLD patients, though the evidence is limited to a single small trial.

7. Dosage Forms and Study Dosages

Clinical studies have not used isolated extracts, capsules, or standardized supplements of T. turanicum. Instead, all human interventions have used whole-food dietary replacement strategies, substituting conventional wheat products with equivalent products made from khorasan wheat flour or semolina. The specific quantities used in the major published trials are as follows:

• ACS trial (Whittaker et al., 2015, Nutrients): Patients were assigned to consume bread, pasta, biscuits, and crackers made from organic semi-whole khorasan wheat or organic semi-whole control wheat for eight weeks. On average, patients ingested 62.0 g dry weight per day of khorasan or control semolina, and 140.5 g dry weight per day of khorasan or control flour.
• IBS trial (Sofi et al., 2014, British Journal of Nutrition): A double-blinded randomised cross-over trial used twenty participants with moderate IBS. Participants received products (bread, pasta, biscuits, and crackers) made either from ancient or modern wheat for 6 weeks in a random order. Symptoms were evaluated at baseline and on a weekly basis during the intervention period.
• T2DM trial (Whittaker et al., 2016/2017, European Journal of Nutrition): A randomized, double-blinded crossover trial with two intervention phases was conducted on 21 T2DM patients (14 females, 7 males). Participants were assigned to consume bread, pasta, crackers, and biscuits made using semi-whole flour from either organic ancient khorasan wheat or modern control wheat for 8 weeks in a random order, with an 8-week washout period between interventions.
• Healthy volunteer antioxidant trial (Dinu et al., 2017, European Journal of Nutrition): A randomized, non-blind, parallel arm study compared biochemical parameters of volunteers whose entire cereal product intake was replaced with organic whole grain KAMUT® khorasan products. A total of 30 healthy volunteers were recruited and the intervention period lasted 16 weeks.
• Cardiovascular/healthy population trial (Sofi et al., 2013, European Journal of Clinical Nutrition): Each participant received weekly: 500 g of pasta, 1,000 g bread, 250 g crackers, and 250 g biscuits. The grain products consumed were either entirely organic modern wheat or organic khorasan wheat and were consumed as the sole grain product for 8 weeks, followed by an 8-week washout period, then a second 8-week crossover round.

No clinically established or pharmacopeial dosage recommendation exists for T. turanicum as a dietary supplement. All studied quantities represent whole-food dietary intakes as part of complete dietary replacement protocols.

8. Safety Considerations and Interactions

8.1 Celiac Disease: Absolute Contraindication

According to a recent European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) position paper, the only suitable treatment for celiac disease (CD) consists of lifelong adherence to a strict gluten-free diet. A gluten-free diet must guarantee the complete elimination of all gluten-containing cereals which, in addition to wheat, rye, and barley, explicitly include khorasan wheat or kamut®, malt, malted barley, spelt, and most of their derivatives.

Gluten is present in all wheat grains and all can induce coeliac disease in genetically susceptible individuals. Analyses show that the protein content of modern bread wheat has decreased over time while starch content increased. Compared to bread wheat, ancient wheats contain more protein and gluten and greater contents of many CD-active epitopes. Consequently, no single wheat type can be recommended as better for reducing the risks of or mitigating the severity of CD.

8.2 Wheat Allergy

Celiac disease has a diverse clinical presentation and is associated with increased risk of autoimmune co-morbidities. Wheat allergy consists of IgE- and non-IgE-mediated reactions. Rapid IgE-mediated reactions are characterized by specific IgE antibodies with symptoms originating especially from the respiratory and gastrointestinal tract. As T. turanicum is a wheat species, it represents a source of wheat allergens and should be avoided by those with confirmed wheat allergy.

8.3 Non-Celiac Wheat Sensitivity (NCWS)

The gluten-free diet has also been suggested for non-celiac gluten/wheat sensitivity (NCG/WS), characterized by intestinal and extraintestinal symptoms induced by gluten ingestion in the absence of celiac disease or wheat allergy. NCG/WS should be regarded as an "umbrella term" including a variety of different conditions where gluten is likely not the only factor responsible for triggering symptoms. Other compounds aside from gluten may be involved, including fructans (part of FODMAPs), amylase trypsin inhibitors (ATIs), and wheat germ agglutinin (WGA).

While some human research suggests that replacing modern wheat with T. turanicum products may reduce symptoms in IBS patients, Khorasan wheat contains gluten and is not safe for people with celiac disease. Although its protein profile differs from modern wheat, tolerance varies by individual.

8.4 Gluten Content Relative to Modern Wheat

Different types of wheat contain varying amounts of gluten. In comparison to modern wheat cultivars, Khorasan wheat usually contains higher protein levels and subsequently higher gluten content. Claims circulating in popular media that ancient wheats such as Khorasan are lower in gluten than modern wheats are not supported by comparative protein analyses.

8.5 Industry Funding as a Research Consideration

A significant portion of the published khorasan wheat clinical research has been supported in part by a grant from the Kamut Enterprises of Europe (KEE), Oudenaarde, Belgium. While this does not invalidate study findings, it represents a methodological consideration that should be weighed when interpreting the evidence base. Independent replication of results by research groups without industry ties is needed to fully corroborate the reported effects.

8.6 Selenium Variability and Soil Dependence

The high selenium concentrations found in KAMUT® brand products are closely related to the geology of North American soils in Montana and Saskatchewan, which are naturally rich in this mineral. In khorasan grown in the Mediterranean area, the selenium content reflects the local soil availability. This means the nutritional composition — and by extension the potential health effects — of T. turanicum products may differ substantially depending on where the grain is grown, limiting the generalizability of findings from studies conducted exclusively with North American-grown KAMUT® to khorasan wheat grown elsewhere.

8.7 FODMAP Considerations

Suspected triggers of symptoms in non-celiac wheat sensitivity include gluten, fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), and wheat α-amylase trypsin inhibitors (ATIs). Khorasan wheat accessions display elevated levels of raffinose, stachyose, fructose, and maltose. Individuals with FODMAP sensitivity should be aware that the elevated levels of certain fermentable oligosaccharides in T. turanicum could be relevant to symptom triggers, independent of its gluten content.

9. Overall Evidence Summary and Limitations

Triticum turanicum (khorasan wheat) has an established and well-characterized nutritional profile that is compositionally superior to modern T. aestivum and T. durum in several respects, including protein, selenium (in North American-grown cultivars), polyphenol diversity, and carotenoid content. A coherent and growing body of small randomized crossover clinical trials — predominantly by a single Italian research group (Sofi, Whittaker, and colleagues at the University of Florence) — has documented improvements in cardiovascular risk markers, IBS symptoms, glycemic and lipid parameters in T2DM, and antioxidant status following dietary replacement with khorasan wheat products.

However, the overall evidence must be characterized as preliminary for the following reasons: all human trials to date use small samples (20–30 participants); the vast majority of clinical research originates from a single research group and has received industry funding from KAMUT® trademark holders; no studies have isolated specific constituents to identify which component is responsible for observed effects; the intervention modality (whole dietary replacement) does not map to typical supplement use; and selenium content — which may be a key driver of antioxidant effects — varies dramatically with soil geography, meaning that products grown outside North America cannot be assumed to confer the same effects. No regulatory health claims for T. turanicum have been established by agencies such as EFSA, the FDA, or WHO.

References

• Wikipedia: Khorasan wheat
• Grausgruber et al. (2005). Yield and agronomic traits of Khorasan wheat (Triticum turanicum Jakubz.). Field Crops Research, 91, 319–327. ScienceDirect.
• Whittaker A et al. (2015). An Organic Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients with Acute Coronary Syndrome: A Randomized Crossover Trial. Nutrients, 7(5), 3401–3415. PMC.
• Sofi F et al. (2014). Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial. British Journal of Nutrition, 111, 1992–1999. PubMed.
• Sofi F et al. (2014). Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome. PMC Full Text.
• Whittaker A et al. (2017). A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial. European Journal of Nutrition, 56(3), 1191–1200. PubMed.
• Whittaker A et al. (2017). A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM). PMC Full Text.
• Dinu M et al. (2018). Evaluation of antioxidative and diabetes-preventive properties of an ancient grain, KAMUT® khorasan wheat, in healthy volunteers. European Journal of Nutrition. PMC.
• Dinu M et al. (2018). Evaluation of antioxidative and diabetes-preventive properties of KAMUT® khorasan wheat. European Journal of Nutrition. Springer.
• Bordoni A et al. (2017). Ancient wheat and health: a legend or the reality? A review on KAMUT khorasan wheat. International Journal of Food Sciences and Nutrition. Taylor & Francis.
• Nutritional and nutraceutical aspects of KAMUT® khorasan wheat grown during the last two decades. Journal of Agricultural Science. Cambridge Core.
• Palombieri S et al. (2024). Characterization of Triticum turgidum sspp. durum, turanicum, and polonicum grown in Central Italy in relation to technological and nutritional aspects. Frontiers in Plant Science. PMC.
• Evaluation of agronomic and nutritional traits in Khorasan wheat (Triticum turgidum subsp. turanicum) under Korean conditions. Journal of Food Composition and Analysis. ScienceDirect (2025).
• Comparison of metabolite profiles and policosanol contents in the sprout of Oriental wheat cultivars (Triticum turgidum ssp. turanicum). PMC (2025).
• Do ancient types of wheat have health benefits compared with modern bread wheat? PMC.
• Counteraction of oxidative damage in the rat liver by an ancient grain (Kamut brand khorasan wheat). Nutrition. ScienceDirect.
• Do ancient wheats contain less gluten than modern bread wheat, in favour of better health? PMC.
• The follow-up of patients with celiac disease. PMC (2025).
• A Khorasan Wheat-Based Replacement Diet Improves Systemic Inflammatory Profile in Semi-Professional Basketball Players. PubMed (2019).
• KAMUT® Brand Wheat Research Summary. Kamut International.